On March 5, 2025, Sri Lanka’s National Medicines Regulatory Authority (NMRA) issued an announcement introducing new requirements for borderline products, covering registration, customs clearance, ingredient guidelines, and labeling.
On March 5, 2025, Sri Lanka’s National Medicines Regulatory Authority (NMRA) issued an announcement introducing new requirements for borderline products, covering registration, customs clearance, ingredient guidelines, and labeling.